Progress with infliximab biosimilars for inflammatory bowel disease
Author:
Affiliation:
1. First Department of Medicine, Semmelweis University, Budapest, Hungary
2. Division of Gastroenterology, McGill University Health Center, Montreal, QC, Canada
Funder
not funded
Publisher
Informa UK Limited
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14712598.2018.1469620
Reference44 articles.
1. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study
2. Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up
3. Biological therapy in inflammatory bowel diseases: Access in Central and Eastern Europe
4. A Nationwide 2010–2012 Analysis of U.S. Health Care Utilization in Inflammatory Bowel Diseases
5. Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study;Gastroenterología y Hepatología (English Edition);2024-06
2. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study;Gastroenterología y Hepatología;2023-08
3. Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?;Drugs;2021-10-27
4. Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease;Gastroenterology;2021-06
5. The global landscape on interchangeability of biosimilars;Expert Opinion on Biological Therapy;2021-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3